Dr. Nicholas A. Haglund, MD

Dr. Haglund practices at Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health.

Dr. Haglund's NPI, 1023199189, was assigned on October 17, 2006. Dr. Haglund holds Minnesota license 70340.

Dr. Haglund's primary practice is Abbott Northwestern Hospital, at 800 East 28th Street, Minneapolis, MN 55407 in Hennepin County. The practice phone is (612) 863-4000.

Dr. Haglund's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dr. Haglund is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Haglund to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haglund practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Haglund's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Haglund is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dr. Haglund is licensed in Minnesota.

CMS data shows 525 Medicare services from Dr. Haglund across 12 procedure codes in 2024, for 289 Medicare patients. Medicare paid $47,323 for them.

CMS counts 289 Medicare patients who saw Dr. Haglund in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have heart failure, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haglund's median patient age at 68, with 34% women.

In 2024, Dr. Haglund wrote 3,068 Medicare Part D claims for 363 patients. 64% of them were for generic drugs. CMS names the drug for 2,895 of them, across 34 drugs with 11 or more claims each, at $3,196,650 in total drug cost. In 2023, CMS named 2,098 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Haglund for performance year 2024, reported as part of a group. Dr. Haglund accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haglund as offering telehealth.

Dmand AI links 54 papers to Dr. Haglund, published from 2011 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Heart-Assist Devices, Heart Failure and Heart Transplantation. Dr. Haglund has published most often in ASAIO J. Dr. Haglund's most frequent co-authors are Mary E. Keebler, Keith David Aaronson, MD and Andrew J. Sauer, MD.

Dmand AI links Dr. Haglund to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Respiratory Aspiration and Cardiomyopathies.

CMS Open Payments shows 89 general payments to Dr. Haglund from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. CVRx, Inc. paid the most, $9,193.